Paper Title:
In Vivo Biocompatibility of a Novel Ceramic-Metal Biocomposite
  Abstract

An in vivo biocompatibility test of a novel biocomposite, with major phases of CaTiO3 and Ti2O, and minor phases of AlTi3, TiO, CaO and Al2O3, was conducted on rats using subcutaneous implantation. The biocomposite and titanium alloy control specimens were removed at 6 and 14 weeks post-implantation. Histological examination revealed no significant adverse reaction of the surrounding tissue to the either the biocomposite or the control material. We conclude that the composite is well tolerated in a physiological environment.

  Info
Periodical
Key Engineering Materials (Volumes 284-286)
Main Theme
Edited by
Panjian Li, Kai Zhang and Clifford W. Colwell, Jr.
Pages
807-810
DOI
10.4028/www.scientific.net/KEM.284-286.807
Citation
D. Ying, L.X. Luo, B. Young, A.F. Julian, "In Vivo Biocompatibility of a Novel Ceramic-Metal Biocomposite", Key Engineering Materials, Vols. 284-286, pp. 807-810, 2005
Online since
April 2005
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: C. Mangano, A. Scarano, Roberta Martinetti, L. Dolcini
829
Authors: Ji Yong Chen, You Rong Duan, Xing Dong Zhang
Abstract:Two sets of porous biphasic calcium phosphate ceramics (BCP) were prepared for dynamic SBF experiment: porous BCP with micropores on the...
289
Authors: Min Wang
Abstract:Metallic biomaterials such as stainless steel and Co-based alloys are corrosion resistant and possess excellent mechanical properties and...
285
Authors: Jun Zhao, Zhi Ming Yu, Kun Yu, Liang Jian Chen
Abstract:The Mg-6%Zn-5%Hydroxyapatite (HA) biomaterial had been prepared through powder metallurgy method in this investigation. The mechanical...
1287
Authors: H. Valiense, G.V.O. Fernandes, B. Moura, J. Calasans-Maia, A. Alves, Antonella M. Rossi, J.M. Granjeiro, M. Calasans-Maia
Abstract:The objective of this study was to investigate the bone repair of carbonate apatite (cHA) in comparison to hydroxyapatite (HA, control...
258